150 related articles for article (PubMed ID: 27973619)
21. Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder.
Jarskog LF; Hamer RM; Catellier DJ; Stewart DD; Lavange L; Ray N; Golden LH; Lieberman JA; Stroup TS;
Am J Psychiatry; 2013 Sep; 170(9):1032-40. PubMed ID: 23846733
[TBL] [Abstract][Full Text] [Related]
22. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
[TBL] [Abstract][Full Text] [Related]
23. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
24. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
Henderson DC; Kunkel L; Nguyen DD; Borba CP; Daley TB; Louie PM; Freudenreich O; Cather C; Evins AE; Goff DC
Acta Psychiatr Scand; 2006 Feb; 113(2):142-7. PubMed ID: 16423166
[TBL] [Abstract][Full Text] [Related]
25. Metformin-induced acute dystonia in a schizophrenic patient treated with sulpiride and clozapine.
Chen WH; Huang WL; Hsieh MH
Psychiatry Clin Neurosci; 2016 Aug; 70(8):362-3. PubMed ID: 27193328
[No Abstract] [Full Text] [Related]
26. Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.
Baptista T; Sandia I; Lacruz A; Rangel N; de Mendoza S; Beaulieu S; Contreras Q; Galeazzi T; Vargas D
Int Clin Psychopharmacol; 2007 Mar; 22(2):69-76. PubMed ID: 17293706
[TBL] [Abstract][Full Text] [Related]
27. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
[TBL] [Abstract][Full Text] [Related]
28. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A
J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221
[TBL] [Abstract][Full Text] [Related]
30. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study.
Yi Z; Fan X; Wang J; Liu D; Freudenreich O; Goff D; Henderson DC
Psychiatry Res; 2012 Dec; 200(2-3):79-82. PubMed ID: 22727707
[TBL] [Abstract][Full Text] [Related]
32. [The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial].
Holka-Pokorska JA; Radzio R; Jarema M; Wichniak A
Psychiatr Pol; 2015; 49(2):363-76. PubMed ID: 26093599
[TBL] [Abstract][Full Text] [Related]
33. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.
Freudenreich O; Henderson DC; Walsh JP; Culhane MA; Goff DC
Schizophr Res; 2007 May; 92(1-3):90-4. PubMed ID: 17321111
[TBL] [Abstract][Full Text] [Related]
34. Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia.
Henderson DC; Freudenreich O; Borba CP; Wang X; Copeland PM; Macklin E; Fan X; Cather C; Goff DC
Schizophr Res; 2011 Aug; 130(1-3):53-6. PubMed ID: 21565464
[TBL] [Abstract][Full Text] [Related]
35. Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.
Krakowski M; Czobor P; Citrome L
Schizophr Res; 2009 May; 110(1-3):95-102. PubMed ID: 19269139
[TBL] [Abstract][Full Text] [Related]
36. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial.
Fleming R; Hopkinson ZE; Wallace AM; Greer IA; Sattar N
J Clin Endocrinol Metab; 2002 Feb; 87(2):569-74. PubMed ID: 11836287
[TBL] [Abstract][Full Text] [Related]
37. Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis.
Liu Z; Zheng W; Gao S; Qin Z; Li G; Ning Y
Shanghai Arch Psychiatry; 2015 Dec; 27(6):331-40. PubMed ID: 27199524
[TBL] [Abstract][Full Text] [Related]
38. Weight gain during a double-blind multidosage clozapine study.
de Leon J; Diaz FJ; Josiassen RC; Cooper TB; Simpson GM
J Clin Psychopharmacol; 2007 Feb; 27(1):22-7. PubMed ID: 17224708
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
[TBL] [Abstract][Full Text] [Related]
40. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
